Cytodyn Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Cytodyn

Access the complete profile.

Cytodyn Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	1111 Main St Ste 660 Vancouver, WA 98660

Note: Revenues for privately held companies are statistical evaluations.


Cytodyn's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Cytodyn's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Cytodyn is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Cytodyn Annual Revenue and Growth Rate

Cytodyn	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$1 - $10 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Cytodyn's revenues are gauged from an analysis of company filings.

Cytodyn's Income Statement (based on Industry Averages)

Cytodyn P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Cytodyn has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
September 19, 2022	166	100%	$22 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Cytodyn is developing and marketing. Cytodyn doesn't have any recent trademark applications, indicating Cytodyn is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
CYTODYN Biological products in the nature of antibodies for use in the manufacture of medicines and pharmaceuticals for treating human immunodeficiency virus infections, sold as an integral component of medicines and pharmaceuticals for treating human immunodeficiency virus infections	06/15/2020
LAMP therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19	02/06/2020
IMMUVANCE therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19	01/08/2020

See all trademarks and details in the Full Report.

Market Share of Cytodyn's Largest Competitors

A competitive analysis shows these companies are in the same general field as Cytodyn, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Cytodyn. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
NLIGHT	Camas, WA	100
ABSCI	Vancouver, WA	7
CAPSIGEN	Vancouver, WA	3
SURGICAL TRAINING INSTITUTE	Camas, WA	3
CYTODYN	Vancouver, WA	1
FATHOM INSIGHT	Vancouver, WA	1

Future Competition: Cytodyn's Fastest Growing Competitors

These companies are in the same general field as Cytodyn and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)